Skip to main content

Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

AUDUBON, Pa., March 05, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it is scheduled to participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego. Management is scheduled to present on Monday, March 10, 2025 at 4:30 pm PT.

Interested parties can access the live and archived webcast of the presentation in the “News & Events”, “Events & Webcasts” section of the Globus Medical investor relations website at https://www.investors.globusmedical.com/news-events/events-webcasts.  

About Globus Medical, Inc. 
Based in Audubon, Pennsylvania, Globus Medical, Inc. is a leading global musculoskeletal technology company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, regenerative biomaterials and enabling technologies. Additional information can be accessed at www.globusmedical.com.  

Investor contact: 
Brian Kearns 
610-930-1800 
investors@globusmedical.com 

Media contact: 
Moran Chavez 
media@globusmedical.com 


Primary Logo

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  248.34
-0.16 (-0.06%)
AAPL  263.73
-2.70 (-1.02%)
AMD  275.01
+16.89 (6.54%)
BAC  53.73
-0.59 (-1.10%)
GOOG  332.25
-2.22 (-0.66%)
META  673.92
+2.34 (0.35%)
MSFT  418.31
+7.09 (1.72%)
NVDA  198.31
-0.56 (-0.28%)
ORCL  177.08
+7.27 (4.28%)
TSLA  387.53
-4.42 (-1.13%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.